Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Accounts Payables (2023 - 2025)

BrightSpring Health Services' Accounts Payables history spans 3 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Accounts Payables rose 31.82% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 31.82%, while the annual FY2025 figure was $1.2 billion, 31.82% up from the prior year.
  • Accounts Payables reached $1.2 billion in Q4 2025 per BTSG's latest filing, up from $954.5 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.2 billion in Q4 2025 to a low of $641.6 million in Q4 2023.
  • Average Accounts Payables over 3 years is $853.4 million, with a median of $868.1 million recorded in 2025.
  • The largest YoY upside for Accounts Payables was 44.2% in 2025 against a maximum downside of 21.77% in 2025.
  • A 3-year view of Accounts Payables shows it stood at $641.6 million in 2023, then soared by 44.0% to $923.9 million in 2024, then skyrocketed by 31.82% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Accounts Payables are $1.2 billion (Q4 2025), $954.5 million (Q3 2025), and $965.3 million (Q2 2025).